首页> 外文期刊>BMC Pregnancy and Childbirth >Effect of maternal supplement beverage with and without probiotics during pregnancy and lactation on maternal and infant health: a randomized controlled trial in the Philippines
【24h】

Effect of maternal supplement beverage with and without probiotics during pregnancy and lactation on maternal and infant health: a randomized controlled trial in the Philippines

机译:孕期和哺乳期含或不含益生菌的母体补充饮料对母婴健康的影响:菲律宾的一项随机对照试验

获取原文
           

摘要

Adequate nutrition is essential during pregnancy and lactation to provide sufficient energy and nutrients to meet the nutritional requirements of the mother, fetus and infant. The primary objective of this study was to assess the effect of a maternal nutritional supplement enriched with probiotics during pregnancy and early lactation on the incidence of infant diarrhea. Healthy, pregnant (24–28?weeks gestation) women were randomized 1:1:1 to receive either no supplement or two servings per day of an oral supplement (140?kcal/serving) providing 7.9?g protein, multivitamin/minerals, and enriched or not with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis, from the third trimester of pregnancy until at least 2?months post-delivery. Incidence of infant diarrhea until 12?months post-delivery was analyzed by Poisson regression. The effect on maternal health, fetal growth, and infant growth and morbidity were also evaluated and analyzed by ANOVA. A total of 208 mother/infant pairs were included in the analysis. No significant difference in the incidence of infant diarrhea was observed between the three study groups. The mean maternal weight gains at delivery were similar among groups, despite an increase in caloric intake in the supplemented groups. No statistically significant differences between groups were observed in incidence of pregnancy-related or fetal adverse outcomes. Mean weight-, length-, BMI- and head circumference-for-age z-scores were below the WHO median value for all groups. Post-hoc analysis to compare the effect of the combined supplement groups versus the no supplement group on infant growth parameters showed, at 12?months, that the combined supplemented group had gained statistically significant more weight (8.97 vs. 8.61?kg, p?=?0.001) and height (74.2 vs. 73.4?cm, p?=?0.031), and had a higher weight-for-age z-score (??0.62 vs. -0.88, p?=?0.045) than the no supplement group. Maternal nutritional supplement with or without probiotics given during late pregnancy and early lactation was well tolerated and safe. Even though no difference in incidence of infant diarrhea was observed between the three groups, the analysis of the combined supplemented groups showed beneficial effects of maternal supplementation on infant weight and length gains at 12?months. ClinicalTrial.gov: NCT01073033 . Registered 17.02.2010.
机译:怀孕和哺乳期间要有足够的营养,以提供足够的能量和营养,以满足母亲,胎儿和婴儿的营养需求。这项研究的主要目的是评估孕期和早期哺乳期富含益生菌的孕产妇营养补充剂对婴儿腹泻发生率的影响。健康的孕妇(妊娠24-28周)按1:1:1的比例随机分配,不接受补品,也不接受每天两次口服补品(140千卡/份),提供7.9克蛋白质,多种维生素/矿物质,从妊娠中期到分娩后至少2个月,是否富含益生菌鼠李糖乳杆菌和乳酸双歧杆菌。通过泊松回归分析婴儿直到分娩后12个月的腹泻发生率。还通过方差分析评估和分析了对孕产妇健康,胎儿生长以及婴儿生长和发病率的影响。分析中总共包括208对母亲/婴儿。在三个研究组之间,婴儿腹泻的发生率没有显着差异。尽管补充组的热量摄入有所增加,但各组孕妇平均体重增加相似。两组之间在妊娠相关或胎儿不良结局的发生率上没有统计学差异。所有年龄组的平均体重,体长,BMI和头围z得分均低于WHO的中值。事后分析,比较联合补充组和不补充组对婴儿生长参数的影响,结果显示,在12个月时,联合补充组的体重增加了统计学上显着(8.97 vs. 8.61kg kg,p?)。 = 0.001)和身高(74.2 vs. 73.4?cm,p?=?0.031),并具有更高的年龄重量z分数(?0.62 vs.-0.88,p?=?0.045)。没有补充组。在妊娠晚期和早期哺乳期给予或不给予益生菌的孕妇营养补充剂耐受性和安全性良好。即使在三组之间未观察到婴儿腹泻的发生率有差异,但对合并补充组的分析显示,母体补充对12个月大的婴儿体重和身长增加有有益的作用。 ClinicalTrial.gov:NCT01073033。注册2010年2月17日。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号